Full-Time

Manager – Data Science and AI

Posted on 3/13/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

No salary listed

Senior

Mumbai, Maharashtra, India

Category
Data Science
Data & Analytics
Required Skills
Python
NoSQL
Data Science
R
SQL
Machine Learning
Java
Tableau
Scala
Hadoop
Operations Research
AngularJS
Databricks
Data Analysis
Snowflake
Requirements
  • Bachelor’s degree with 5-8 years of experience, preferably in Engineering, Economics, Statistics, Computer science, or related quantitative field.
  • Advanced degree preferred with 0-2 years of experience in Applied Econometrics, Statistics, Data Mining, Machine Learning, Analytics, Mathematics, Operations Research, Industrial Engineering, or related field preferred.
  • Experience using Data Science models to solve problems in an education or business environment setting.
  • Experience with both traditional SQL and modern NoSQL data stores including SQL, and large-scale distributed systems such as Hadoop and or working in Snowflake/Databricks.
  • Experience with machine learning technology, such as: big data stack, Java, Python, R, Scala and visualization techniques, including Dash, Tableau and Angular.
Responsibilities
  • Deliver advanced analytical models, predictive algorithms, and AI-powered tools to extract actionable insights to drive US Commercial strategies and tactics.
  • Support the end-to-end delivery of data science insights, from framing the business question, designing the solution, and delivering recommendations.
  • Break down technical concepts into digestible insights and guide diverse stakeholders how to interpret.
  • Build strong relationships with key stakeholders, effectively communicating the value proposition of data science.
  • Collaborate within the analytics POD, coordinating efforts with the Insight Strategy & Execution and Market Research Insights counterparts to develop and execute a comprehensive brand analytics plan.
  • Deliver consolidated insights and actionable recommendations to US Commercial teams, ensuring alignment with strategic objectives and insights findings.
  • Represent data science function and capabilities in Analytic POD meetings.
  • Work closely with cross-functional teams to ensure seamless integration of brand analytics insights into decision-making processes and strategic initiatives.
  • Work closely with Analytics Engineering to ensure the data ecosystem is conducive for data science modeling purposes.
  • Partner with Digital teams to enhance data science capabilities, aligning efforts to leverage digital data sources effectively.
  • Foster collaboration with other teams to ensure seamless integration of data science initiatives across the organization's infrastructure, promoting efficiency and effectiveness in leveraging data for informed decision-making.
Desired Qualifications
  • Advanced degree preferred with 0-2 years of experience in Applied Econometrics, Statistics, Data Mining, Machine Learning, Analytics, Mathematics, Operations Research, Industrial Engineering, or related field preferred.
  • Experience in supporting commercial strategies and tactics, experience in pharmaceutical or healthcare industry is preferred.

Pfizer is a biopharmaceutical company that focuses on creating and producing healthcare products, including medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold to various clients such as governments, healthcare providers, and patients around the world. Pfizer's products include vaccines, oncology treatments, and other specialized medicines. A notable achievement is its partnership with BioNTech to develop a vaccine for COVID-19, which has played a significant role in addressing the pandemic. Pfizer aims to improve public health by ensuring access to vaccines, especially for underserved populations, and continues to grow its product offerings with new approvals and treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Activist investor Starboard Value's $1B stake may drive strategic changes and increase value.
  • Pfizer's investment in Enara Bio strengthens its position in the immunotherapy market.
  • Backing Promise Bio aligns with Pfizer's strategy to enhance its precision medicine portfolio.

What critics are saying

  • Emerging biotech companies like Trimtech and Normunity could impact Pfizer's market share.
  • Slowdown in COVID-19 vaccine demand poses potential revenue challenges for Pfizer.
  • Activist investor involvement may pressure Pfizer to alter business strategies.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing R&D capabilities and drug discovery.
  • Pfizer's focus on precision medicine diversifies its therapeutic areas and strengthens its portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance

Company News

Finsmes
Mar 5th, 2025
Trimtech Therapeutics Raises $31M in Seed Funding

Trimtech Therapeutics, a Cambridge, UK-based biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, raised $31M in Seed funding

Business Wire
Jan 16th, 2025
Normunity Closes $75 Million Series B Financing to Advance Lead Drug Program Into the Clinic and Broaden Pipeline of Novel Anti-Cancer Therapies Targeting Untapped Drug Mechanisms

Normunity, a biotechnology company creating novel anti-cancer therapies, today announced that it has closed a Series B financing for $75 million. The

TechCrunch
Oct 23rd, 2024
Promise Bio exits stealth backed by Pfizer and AstraZeneca | TechCrunch

The company has made it easier to test for different protein modifications which are critical to the treatment of autoimmune diseases.

The Wall Street Journal
Oct 7th, 2024
Exclusive | Activist Starboard Value Takes $1 Billion Stake in Pfizer

The drugmaker’s shares have slumped as demand for Covid-19 vaccines and treatments had slowed.

Benzinga
Oct 3rd, 2024
Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens®

New investors Pfizer Ventures and M Ventures co-led the financing, with participation from all existing investors including RA Capital, Samsara BioCapital and SV Health InvestorsEnara Bio's EDAPT® platform is

INACTIVE